Moderna Sues BioNTech/Pfizer?

Robert W. Malone

Before I could even get one cup of coffee down the hatch this morning, I was hit with a barrage of emails, texts, and phone calls asking me for quotes concerning the press release issued by Moderna regarding their decision to sue BioNTech/Pfizer for patent infringement relating to the insanely profitable SARS-CoV-2 mRNA “vaccine” products marketed by BioNTech/Pfizer (“Comirnaty” – licensed but not actually marketed in the USA).

… Let’s take a moment to provide some key details relating to patent law, as there are a few things that one must understand to interpret the new claims being made by Moderna against BioNTech.

… To provide additional context, there is apparently another lawsuit between NIH/NIAID/Vaccine Research Center and Moderna over who owns the rights to the specific vaccine which Moderna has sold to the US Government and throughout the world.

… There is also a lawsuit battle ongoing between the cationic lipid formulation companies which were spun out of the University of British Columbia – Arbutus and Alnylam, which some in Canada believe are owned to a significant extent by the family of Justin Trudeau.

… Moderna is asserting that it has patent rights relating to both broad fundamental composition of the mRNA as a (modified) chemical structure, and to the use of any full length coronavirus spike protein in a lipid nanoparticle formulation for a coronavirus (vaccine).

Latest articles

Non-GMO Project Is it possible to create a non-GMO product using genetic...
Carlos A. Monteiro Orthodox teaching and practice on nutrition and health almost...
What They Don’t Want to Tell You About Genetically Modified Crops and...
Environmental Health Symposium While we were distracted with Covid-19, lockdowns, mask mandates,...
Royal Lee “There is only one test for safety and wholesomeness in...
Weston A. Price Foundation WE HAVE ALWAYS PROCESSED OUR FOOD; this is...

Thank you!

The form has been submitted successfully!